Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Lineage Cell Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −7 vs. Q1 2023
- Shares held
- 75.6M
- +6.28M (+9.1%) vs. Q1 2023
- Total value
- $106.6M
- +$2.46M (+2.4%) vs. Q1 2023
- New holders
- 27
- 25 more added
- Sold out
- 34
- 17 more reduced
2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Central Trust Co | 29 | $41 | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 29 | $41 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 14 | $20 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 8 | $11 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 5 | $7 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 2 | $3 | 0.00% | +2 | New |
| Hantz Financial Services, Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,402,123−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −221,946−100.0% | Sold out |
| Lincoln National Corp | 0 | $0 | 0.00% | −156,225−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −128,840−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −83,395−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −74,560−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −66,298−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −56,626−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −56,362−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −55,646−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −50,875−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −48,000−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −42,591−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −32,143−100.0% | Sold out |
| Strategic Wealth Designers | 0 | $0 | 0.00% | −31,530−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −30,155−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −23,998−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −22,987−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,300−100.0% | Sold out |
| Allegheny Financial Group LTD | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,521−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,688−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,538−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −13,786−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −13,377−100.0% | Sold out |
| Moors & Cabot, Inc. | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −2,237−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −611−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Strategic Investment Solutions, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |
| CTC Capital Management, LLC | – | – | – | – | Not filed |